A Randomized Placebo-Controlled Phase II Trial Evaluating the Effect of Hedgehog Inhibitor LDE225 on Bone Marrow Disseminated Tumor Cells in Women With Early Stage Estrogen Receptor Negative and HER2 Negative Breast Cancer
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 30 Apr 2015
At a glance
- Drugs Sonidegib (Primary)
- Indications Advanced breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 31 Mar 2015 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 06 May 2014 According to ClinicalTrials,gov record, status changed from not yet recruiting to recruiting.